Amryt Pharma plc (AMYT) Revenue Breakdown by Product - Discounting Cash Flows
AMYT
Amryt Pharma plc
AMYT (NASDAQ)
Period Ending: 2021
12-31
2020
12-31
Total
1234
Mycapssa
1234
Mycapssa (%)
1234
Lomitapide
1234
Lomitapide (%)
1234
Metreleptin
1234
Metreleptin (%)
1234
Other
1234
Other (%)
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program